THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Point72 Asset Management, L.P.'s Holding History (CIK: 0001603466)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 12,692 Value ($000) $140 Avg Close $9.72 Range $7.90 - $11.82

Q2 2022

Shares 105,900 Value ($000) $959 Avg Close $9.21 Range $8.15 - $10.52

Q1 2022

Shares 656,100 Value ($000) $6,272 Avg Close $9.80 Range $7.71 - $13.17

Q4 2021

Shares 145,100 Value ($000) $1,603 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 3,405,602 Value ($000) $25,201 Avg Close $11.19 Range $6.10 - $15.01

Q1 2017

Shares 90,700 Value ($000) $3,340 Avg Close $31.95 Range $27.80 - $37.18

Q4 2016

Shares 170,700 Value ($000) $5,442 Avg Close $31.02 Range $24.54 - $38.92

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	12,692	$140	$9.72	$7.90 - $11.82
Q2 2022	105,900	$959	$9.21	$8.15 - $10.52
Q1 2022	656,100	$6,272	$9.80	$7.71 - $13.17
Q4 2021	145,100	$1,603	$8.72	$7.30 - $11.24
Q3 2021	3,405,602	$25,201	$11.19	$6.10 - $15.01
Q1 2017	90,700	$3,340	$31.95	$27.80 - $37.18
Q4 2016	170,700	$5,442	$31.02	$24.54 - $38.92